Below, we describe our current knowledge of CD4+ T-cell responses in IBD in the context of the studied patient material (e.g., intestinal biopsies, blood and plasma) and address whether changes in CD4+ T-cell responses may possibly be used to stratify subgroups of IBD patients with similar immune pathways involved in disease pathogenesis [55]. Here, CD4 is linked to inflammatory bowel disease.